Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kotaro Shide

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Journal of Clinical and Experimental Hematopathology : JCEH|March 24, 2017
TET2 mutation in diffuse large B-cell lymphomaYoko Kubuki, Takumi Yamaji, Tomonori Hidaka, et al.
International Journal of Hematology|July 11, 2018
Early/prefibrotic primary myelofibrosis in patients who were initially diagnosed with essential thrombocythemiaAyako Kamiunten, Kotaro Shide, Takuro Kameda, et al.
International Journal of Hematology|March 1, 2018
Thrombohemorrhagic events, disease progression, and survival in polycythemia vera and essential thrombocythemia: a retrospective survey in Miyazaki prefecture, JapanAyako Kamiunten, Kotaro Shide, Takuro Kameda, et al.
European Journal of Haematology|December 10, 2020
Higher average chemotherapy dose intensity improves prognosis in patients with aggressive adult T-cell leukemia/lymphomaMasaaki Sekine, Takuro Kameda, Kotaro Shide, et al.
International Journal of Clinical Oncology|September 10, 2011
Clinical features and treatment outcomes of isolated secondary central nervous system lymphomas in Miyazaki PrefectureNoriaki Kawano, Hidenobu Ochiai, Shuro Yoshida, et al.
Annals of Hematology|May 31, 2012
Potentiated activation of VLA-4 and VLA-5 accelerates proplatelet-like formationTakuya Matsunaga, Fumio Fukai, Takuro Kameda, et al.
Blood Neoplasia|September 15, 2025
TYK2 is essential for the therapeutic effect of IFN-α in <i>Jak2</i>V617F-induced murine myeloproliferative neoplasmsYuki Tahira, Kotaro Shide, Takuro Kameda, et al.
Blood Cancer Journal|March 31, 2019
Mice with Calr mutations homologous to human CALR mutations only exhibit mild thrombocytosisKotaro Shide, Takuro Kameda, Ayako Kamiunten, et al.
Communications Biology|November 29, 2022
CARD11 mutation and HBZ expression induce lymphoproliferative disease and adult T-cell leukemia/lymphomaTakuro Kameda, Kotaro Shide, Ayako Kamiunten, et al.
World Journal of Hepatology|January 24, 2018
Efficacy and safety of sofosbuvir and ledipasvir in Japanese patients aged 75 years or over with hepatitis C genotype 1Yoshinori Ozono, Kenji Nagata, Satoru Hasuike, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Journal of Clinical and Experimental Hematopathology : JCEH|March 24, 2017
TET2 mutation in diffuse large B-cell lymphomaYoko Kubuki, Takumi Yamaji, Tomonori Hidaka, et al.
International Journal of Hematology|July 11, 2018
Early/prefibrotic primary myelofibrosis in patients who were initially diagnosed with essential thrombocythemiaAyako Kamiunten, Kotaro Shide, Takuro Kameda, et al.
International Journal of Hematology|March 1, 2018
Thrombohemorrhagic events, disease progression, and survival in polycythemia vera and essential thrombocythemia: a retrospective survey in Miyazaki prefecture, JapanAyako Kamiunten, Kotaro Shide, Takuro Kameda, et al.
European Journal of Haematology|December 10, 2020
Higher average chemotherapy dose intensity improves prognosis in patients with aggressive adult T-cell leukemia/lymphomaMasaaki Sekine, Takuro Kameda, Kotaro Shide, et al.
International Journal of Clinical Oncology|September 10, 2011
Clinical features and treatment outcomes of isolated secondary central nervous system lymphomas in Miyazaki PrefectureNoriaki Kawano, Hidenobu Ochiai, Shuro Yoshida, et al.
Annals of Hematology|May 31, 2012
Potentiated activation of VLA-4 and VLA-5 accelerates proplatelet-like formationTakuya Matsunaga, Fumio Fukai, Takuro Kameda, et al.
Blood Neoplasia|September 15, 2025
TYK2 is essential for the therapeutic effect of IFN-α in <i>Jak2</i>V617F-induced murine myeloproliferative neoplasmsYuki Tahira, Kotaro Shide, Takuro Kameda, et al.
Blood Cancer Journal|March 31, 2019
Mice with Calr mutations homologous to human CALR mutations only exhibit mild thrombocytosisKotaro Shide, Takuro Kameda, Ayako Kamiunten, et al.
Communications Biology|November 29, 2022
CARD11 mutation and HBZ expression induce lymphoproliferative disease and adult T-cell leukemia/lymphomaTakuro Kameda, Kotaro Shide, Ayako Kamiunten, et al.
World Journal of Hepatology|January 24, 2018
Efficacy and safety of sofosbuvir and ledipasvir in Japanese patients aged 75 years or over with hepatitis C genotype 1Yoshinori Ozono, Kenji Nagata, Satoru Hasuike, et al.
Pageof 7